Concepedia

Prexton Therapeutics (Switzerland)

PT

Statistics

Publications

7

Citations

1.1K

Authors

2

Location

Geneva, Switzerland

Prexton Therapeutics (Switzerland) is a company institution in Geneva, Switzerland known for natural sciences, molecular physiology, and molecular neuroscience.

HomepageROR

Top concepts

Publications

7

An m<scp>G</scp>lu4‐<scp>P</scp>ositive <scp>A</scp>llosteric <scp>M</scp>odulator <scp>A</scp>lleviates <scp>P</scp>arkinsonism in <scp>P</scp>rimates

Delphine Charvin, Thérèse Di Paolo, Erwan Bézard et al. · Movement Disorders · 2018 · 57 citations

Discovery, Structure–Activity Relationship, and Antiparkinsonian Effect of a Potent and Brain-Penetrant Chemical Series of Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4

Delphine Charvin, Vincent Pomel, Millán Ortiz et al. · Journal of Medicinal Chemistry · 2017 · 43 citations · Full text

A Randomized, <scp>Double‐Blind</scp>, Controlled Phase <scp>II</scp> Study of Foliglurax in Parkinson's Disease

Olivier Rascol, Rossella Medori, Corine Baayen et al. · Movement Disorders · 2022 · 39 citations · Full text

Characterization of [11C]PXT012253 as a PET Radioligand for mGlu4 Allosteric Modulators in Nonhuman Primates

Akihiro Takano, Sangram Nag, Zhisheng Jia et al. · Molecular Imaging and Biology · 2018 · 14 citations

, , +10

1–4 of 7

Authors

2

  1. VP
    Vincent Pomel

    Prexton Therapeutics (Switzerland), Switzerland

    2 publications · 248 citations

    2

    h-index

  2. RR
    Rachel Rudigier

    Prexton Therapeutics (Switzerland), Switzerland

    1 publications · 43 citations

    1

    h-index

1–2 of 2